Supervised atenolol therapy in the management of hemodialysis hypertension

Kidney International

Volumn 55, Issue 4, 1999, Pages 1528-1535

  Agarwal, Rajiv ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Antihypertensive agents; Atenolol; Beta blocker; Blood pressure; Renal failure

Indexed keywords

ATENOLOL;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART RATE; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPOTENSION; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL;

EID: 0032920895     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00359.x     Document Type: Article

References (22)

1. CHARRA B, CALEMARD E, RUFFET M, CHAZOT C, TERRAT J, VANEL T, LAURENT G: Survival as an index of adequacy of dialysis. Kidney Int 41:1286-1291, 1992
2. SILBERBERG JS, BARRE PE, PRICHARD SS, SNIDERMAN AD: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36:286-290, 1989
3. ROSTAND SG, BRUNZELL JD, CANNON ROI, VICTOR RG: Cardiovascular complications in renal failure. J Am Soc Nephrol 2:1053-1062, 1991
4. CHARRA B: Control of blood pressure in long slow hemodialysis. Blood Purif 12:252-258, 1994
5. SALEM MM: Hypertension in the hemodialysis population: A survey of 649 patients. Am J Kidney Dis 26:461-468, 1995
6. JACOBS C, SIMON N, PATTE R, DUPUY CA, SARI R: Control of blood pressure in patients treated by maintenance hemodialysis: Efficacy of dialysis and contribution or antihypertensive drugs. Contrib Nephrol 41:128-136, 1984
7. CHEIGH JS, MILITE C, SULLIVAN JF, RUBIN AL, STENZEL, KH: Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis 19:453-459, 1992
8. KOOMAN JP, GLADZIWA U, BOCKER G, WIJNEN JAG, BORTEL LV, LUIK AJ, DE LEUW PW, HOOFF JPV, LEUNISSEN KML: Blood pressure during the interdialytic period in haemodialysis patients: Estimation of representative blood pressure values. Nephrol Dial Transplant 7:917-923, 1992
9. LUIK AJ, STRUIJK DG, GLADZIWA U, V OLDEN RW, VAN HOOFF JP, DE LEUW PW, LEUNISSEN KML: Diurnal blood-pressure variations in haemodialysis and CAPD patients. Nephrol Dial Transplant 9:1616-1621, 1994
10. BAUMGART P, WALGER P, GEMEN S, VON EIFF M, RAIDT H, RAHN KH: Blood pressure elevation during the night in chronic renal failure, hemodialysis and after renal transplantation. Nephron 57:293-298, 1991
11. VERDECCHIA P, SCHILLACT G, GUERRIERI M, GATTESCHI C, BENEMIO G, BOLDRINI F, PORCELLATI C: Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81:528-536, 1990
12. RITZ E, KOCH M: Morbidity and mortality due to hypertension in patients with renal failure. Am J Kidney Dis 21(Suppl 2):113-118, 1993
13. RITZ E: Hypertension and cardiac death in dialysis patients: Should target blood pressure be lowered? Semin Dial 6:227-228, 1993
14. NEUTEL JM, SMITH DHG, RAM CVS, KAPLAN NM, PAPADEMETRIOU V, FAGAN TC, LEFKOWITZ MP, KAZEMPOUR MK, WEBER MA: Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents. Am J Med 94:181-187, 1993
15. FLOUVAT B, DECOURT S, AUBERT P, POTAUX L, DOMART M, GOUPIL A, BAGLIN A: Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis. Br J Clin Pharmacol 9:379-385, 1980
16. FITZGERALD JD, RUFFIN R, SMEDSTAD KG, ROBERTS R, MCAINSH J: Studies on the pharmacokinetics and pharmacodynamics of atenolol in man. Eur J Clin Pharmacol 13:81-89, 1978
17. KIRCH W, KOHLER H, MUTSCHLER E, SCHAFER M: Pharmacokinetics of atenolol in relation to renal function. Eur J Clin Pharmacol 19: 65-71, 1981
18. NIEDERMAYER W, SEILER K, WASSERMAN O: Pharmacokinetics of antihypertensive drugs (atenolol, metoprolol, propranolol and clonidine) and their metabolites during intermittent haemodialysis in humans. Proc Eur Dial Transplant Assoc 15:607-609, 1978
19. BLOMQVIST I, WESTERGREN G, SANDBERG A, JONSSON UE, LUND-BORG P: Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: A comparison with atenolol. Eur J Clin Pharmacol 33(Suppl):S19-S24, 1988
20. DE FREMONT JF, COEVOET B, ANDREJAK M, MAKDASSI R, QUICHAUD J, LAMBREY G, GUERIS J, CAILLENS C, HARICHAUX P, ALEXANDRE JM, FOURNIER A: Effects of antihypertensive drugs on dialysis-resistant hypertension, plasma renin and dopamine betahydroxylase activities, metabolic risk factors and calcium phosphate homeostasis: Comparison of metoprolol, alphamethyldopa and clonidine in a cross-over trial. Clin Nephrol 12:198-205, 1979
21. MAGGIORE Q, BIAGINI M, ZOCCALI C, MISEFARI M: Long-term propranolol treatment of resistant arterial hypertension in haemodialysed patients. Clin Sci Mol Med 48:73s-75s, 1975
22. FISHBANE, S, NATKE E, MESAKA JK: Role of volume overload in dialysis-refractory hypertension. Am J Kidney Dis 28:257-261, 1997